Vanilla 1.0.3 is a product of Lussumo. More Information: Documentation, Community Support.
All things considered, mainly because of the Iseq being down 113 today, I got to thinking about Elan. For those of you that don't know the story, Elan shares were as high as 22 in early 2005 because of an MS drug they were introducing called Tysabri. The company was thriving and one of the strongest in the market, until a patient died during a trial of the drug later that month. Shares then plummeted by 69%. Ever since they have yo-yoed to the point that one month cannot be predicted from the previous month's results. They have been as high as 15 last June and dropped below 10 in the first few days of this year.
The question is, could it happen again?
I think that Elan was good for one thing - it has given more people the ability to judge when to get out. If the share value drops dramatically then most people who held Elan shares would get out instead of buying more. The lesson was hard but may just prove to be valuable. Holding your nerve and being stupid are two very different things.
1 to 11 of 11